Gil Blum
Stock Analyst at Needham
(3.70)
# 871
Out of 4,667 analysts
305
Total ratings
41.49%
Success rate
9.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $11 | $6.04 | +82.12% | 19 | Nov 20, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $52 | $13.04 | +298.77% | 18 | Nov 19, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $2.22 | - | 5 | Nov 19, 2024 | |
| CELC Celcuity | Reiterates: Buy | $23 | $12.78 | +79.97% | 12 | Nov 15, 2024 | |
| STTK Shattuck Labs | Reiterates: Hold | n/a | $1.11 | - | 15 | Nov 14, 2024 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $6 | $2.01 | +198.51% | 23 | Nov 14, 2024 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.80 | +257.14% | 23 | Nov 13, 2024 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $23 | $10.96 | +109.85% | 3 | Nov 13, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $11 | $4.12 | +166.99% | 4 | Nov 12, 2024 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $7 | $3.58 | +95.53% | 13 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $105 | $87.22 | +20.39% | 21 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $2.50 | +340.00% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $16.94 | +142.03% | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $205 | $110.86 | +84.92% | 24 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $71 | $32.42 | +119.00% | 10 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $9.59 | - | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $22.64 | +28.09% | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $47.26 | +77.74% | 17 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.35 | +640.74% | 13 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $3.99 | +50.38% | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.30 | +207.69% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.98 | +512.24% | 12 | Apr 12, 2024 |
Recursion Pharmaceuticals
Nov 20, 2024
Reiterates: Buy
Price Target: $11
Current: $6.04
Upside: +82.12%
Rocket Pharmaceuticals
Nov 19, 2024
Reiterates: Buy
Price Target: $52
Current: $13.04
Upside: +298.77%
Fate Therapeutics
Nov 19, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.22
Upside: -
Celcuity
Nov 15, 2024
Reiterates: Buy
Price Target: $23
Current: $12.78
Upside: +79.97%
Shattuck Labs
Nov 14, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.11
Upside: -
Taysha Gene Therapies
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $2.01
Upside: +198.51%
Autolus Therapeutics
Nov 13, 2024
Reiterates: Buy
Price Target: $10
Current: $2.80
Upside: +257.14%
Artiva Biotherapeutics
Nov 13, 2024
Reiterates: Buy
Price Target: $23
Current: $10.96
Upside: +109.85%
TScan Therapeutics
Nov 12, 2024
Reiterates: Buy
Price Target: $11
Current: $4.12
Upside: +166.99%
Mereo BioPharma Group
Nov 12, 2024
Reiterates: Buy
Price Target: $7
Current: $3.58
Upside: +95.53%
Nov 8, 2024
Maintains: Buy
Price Target: $96 → $105
Current: $87.22
Upside: +20.39%
Nov 8, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $2.50
Upside: +340.00%
Nov 8, 2024
Reiterates: Buy
Price Target: $41
Current: $16.94
Upside: +142.03%
Nov 7, 2024
Reiterates: Buy
Price Target: $205
Current: $110.86
Upside: +84.92%
Nov 7, 2024
Maintains: Buy
Price Target: $78 → $71
Current: $32.42
Upside: +119.00%
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.59
Upside: -
Nov 6, 2024
Reiterates: Buy
Price Target: $29
Current: $22.64
Upside: +28.09%
Nov 6, 2024
Reiterates: Buy
Price Target: $84
Current: $47.26
Upside: +77.74%
Oct 23, 2024
Reiterates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
Aug 9, 2024
Reiterates: Buy
Price Target: $6
Current: $3.99
Upside: +50.38%
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $1.30
Upside: +207.69%
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $0.98
Upside: +512.24%